Updated on 7 September 2026
Policies for cancer patients
Executive Director at Association of European Cancer Leagues (ECL)
Brussels, Belgium
About
ECL actively contributes to numerous EU-funded research and public health initiatives. In partnership with over 70 partners – including cancer leagues, research institutes, public health organisations, university hospitals, and academic experts – we work to drive progress in cancer prevention and care across Europe.
By using our strong network of partners and fostering connections between researchers, policymakers, and key stakeholders, we help ensure that the findings from EU-funded projects are translated into real-world impact. Our core contributions to these projects include stakeholder engagement, policy recommendations, strategic communications, and dissemination of results.
ECL is also proud to participate in several EU Joint Actions – collaborative initiatives that unite national health authorities, public institutions, and other key stakeholders from multiple EU member states to address specific challenges in cancer prevention, diagnosis, treatment, or care.
As coordinators and consortium partners in various impactful EU projects and Joint Actions, we are committed to strengthening Europe’s collective fight against cancer.
Topic
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Similar opportunities
Project cooperation
Medicinal product regulatory framework and authorisation in the EU
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-14-two-stage Clinical trials for advancing innovative interventions for neurodegenerative diseases
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
Janis Ancans
Senior Expert at Latvian Council of Science
Riga, Latvia
Project cooperation
Key Expertise and Contribution Areas
- Partner seeks Consortium/Coordinator
- Consortium/Coordinator seeks Partners
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
- Clinical trials: HORIZON-MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Leonardo Bertero
EU project manager at INOC - Istituto Nazionale Oncologico Candiolo
Turin, Italy
Project cooperation
Psychosocial cancer survivorship research, intervention development
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Daiga Katrīna Bitēna
Junior researcher, PhD student at Rīga Stradiņš University
Riga, Latvia